Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

2259. Rubin MA, Zhou M, Dhanasekaran
SM, Varambally S, Barrette TR, Sanda MG,
Pienta KJ, Ghosh D, Chinnaiyan AM (2002).
alpha-Methylacyl coenzyme A racemase
as a tissue biomarker for prostate cancer.
JAMA 287: 1662-1670.
2260. Rudrick B, Nguyen GK, Lakey WH
(1995). Carcinoid tumor of the renal pelvis:
report of a case with positive urine cytology.
Diagn Cytopathol 12: 360-363.
2261. Ruijter ET, van de Kaa CA, Schalken
JA, Debruyne FM, Ruiter DJ (1996).
Histological grade heterogeneity in multifocal
prostate cancer. Biological and clinical
implications. J Pathol 180: 295-299.
2262. Rumpelt HJ, Storkel S, Moll R,
Scharfe T, Thoenes W (1991). Bellini duct
carcinoma: further evidence for this rare
variant of renal cell carcinoma.
Histopathology 18: 115-122.
2263. Rundle JS, Hart AJ, McGeorge A,
Smith JS, Malcolm AJ, Smith PM (1982).
Squamous cell carcinoma of bladder. A
review of 114 patients. Br J Urol 54: 522-
526.
2264. Rushton HG, Belman AB, Sesterhenn
I, Patterson K, Mostofi FK (1990). Testicular
sparing surgery for prepubertal teratoma
of the testis: a clinical and pathological
study. J Urol 144: 726-730.
2265. Rustin GJ, Vogelzang NJ, Sleijfer DT,
Nisselbaum JN (1990). Consensus statement
on circulating tumour markers and
staging patients with germ cell tumours.
Prog Clin Biol Res 357: 277-284.
2266. Rutgers JL (1991). Adenomas in the
pathology of intersex syndrome. Hum
Pathol 22: 384-394.
2267. Rutgers JL, Scully RE (1987).
Pathology of the testis in intersex syndromes.
Semin Diagn Pathol 4: 275-291.
2268. Rutgers JL, Scully RE (1991). The
androgen insensitivity syndrome (testicular
feminization): a clinicopathologic study
of 43 cases. Int J Gynecol Pathol 10: 126-
144.
2269. Rutgers JL, Young RH, Scully RE
(1988). The testicular “tumor” of the
adrenogenital syndrome. A report of six
cases and review of the literature on testicular
masses in patients with adrenocortical
disorders. Am J Surg Pathol 12: 503-
513.
2270. Sabroe S, Olsen J (1998). Perinatal
correlates of specific histological types of
testicular cancer in patients below 35
years of age: a case-cohort study based on
midwives’ records in Denmark. Int J
Cancer 78: 140-143.
2271. Sacker AR, Oyama KK, Kessler S
(1994). Primary osteosarcoma of the penis.
Am J Dermatopathol 16: 285-287.
2272. Sahin AA, Myhre M, Ro JY, Sneige N,
Dekmezian RH, Ayala AG (1991).
Plasmacytoid transitional cell carcinoma.
Report of a case with initial presentation
mimicking multiple myeloma. Acta Cytol 35:
277-280.
2273. Saint-Andre JP, Chapeau MC, Pein F
(1988). [Nephroblastoma with symptomatic
neuronal differentiation]. Ann Pathol 8:
144-148.
2274. Saito S, Iwaki H (1999). Mucin-producing
carcinoma of the prostate: review
of 88 cases. Urology 54: 141-144.
2275. Saito T (2000). Glomus tumor of the
penis. Int J Urol 7: 115-117.
2276. Sakamoto N, Tsuneyoshi M, Enjoji M
(1992). Urinary bladder carcinoma with a
neoplastic squamous component: a mapping
study of 31 cases. Histopathology 21:
135-141.
2277. Sakashita N, Takeya M, Kishida T,
Stackhouse TM, Zbar B, Takahashi K
(1999). Expression of von Hippel-Lindau
protein in normal and pathological human
tissues. Histochem J 31: 133-144.
2278. Sakr WA (1999). Prostatic intraepithelial
neoplasia: A marker for high-risk
groups and a potential target for chemoprevention.
Eur Urol 35: 474-478.
2279. Sakr WA, Grignon DJ, Haas GP
(1998). Pathology of premalignant lesions
and carcinoma of the prostate in African-
American men. Semin Urol Oncol 16: 214-
220.
2280. Sakr WA, Haas GP, Cassin BF, Pontes
JE, Crissman JD (1993). The frequency of
carcinoma and intraepithelial neoplasia of
the prostate in young male patients. J Urol
150: 379-385.
2281. Sakr WA, Macoska JA, Benson P,
Grignon DJ, Wolman SR, Pontes JE,
Crissman JD (1994). Allelic loss in locally
metastatic, multisampled prostate cancer.
Cancer Res 54: 3273-3277.
2282. Sakr WA, Tefilli MV, Grignon DJ,
Banerjee M, Dey J, Gheiler EL, Tiguert R,
Powell IJ, Wood DP (2000). Gleason score
7 prostate cancer: a heterogeneous entity?
Correlation with pathologic parameters
and disease-free survival. Urology 56: 730-
734.
2283. Sakr WA, Wheeler TM, Blute M,
Bodo M, Calle-Rodrigue R, Henson DE,
Mostofi FK, Seiffert J, Wojno K, Zincke H
(1996). Staging and reporting of prostate
cancer—sampling of the radical prostatectomy
specimen. Cancer 78: 366-368.
2284. Salem Y, Pagliaro LC, Manyak MJ
(1993). Primary small noncleaved cell lymphoma
of kidney. Urology 42: 331-335.
2285. Salo JO, Rannikko S, Makinen J,
Lehtonen T (1987). Echogenic structure of
prostatic cancer imaged on radical prostatectomy
specimens. Prostate 10: 1-9.
2286. Salo P, Kaariainen H, Petrovic V,
Peltomaki P, Page DC, de la Chapelle A
(1995). Molecular mapping of the putative
gonadoblastoma locus on the Y chromosome.
Genes Chromosomes Cancer 14:
210-214.
2287. Salomao DR, Graham SD, Bostwick
DG (1995). Microvascular invasion in
prostate cancer correlates with pathologic
stage. Arch Pathol Lab Med 119: 1050-1054.
2288. Sanchez-Chapado M, Angulo JC,
Haas GP (1995). Adenocarcinoma of the
rete testis. Urology 46: 468-475.
2289. Sandberg AA (1986). Chromosome
changes in bladder cancer: clinical and
other correlations. Cancer Genet
Cytogenet 19: 163-175.
2290. Sandberg AA, Meloni AM,
Suijkerbuijk RF (1996). Reviews of chromosome
studies in urological tumors. III.
Cytogenetics and genes in testicular
tumors. J Urol 155: 1531-1556.
2291. Sanders ME, Mick R, Tomaszewski
JE, Barr FG (2002). Unique patterns of allelic
imbalance distinguish type 1 from type 2
sporadic papillary renal cell carcinoma.
Am J Pathol 161: 997-1005.
2292. Santos LD, Wong CS, Killingsworth M
(2001). Cystadenoma of the seminal vesicle:
report of a case with ultrastructural
findings. Pathology 33: 399-402.
2293. Sarkis AS, Bajorin DF, Reuter VE,
Herr HW, Netto G, Zhang ZF, Schultz PK,
Cordon-Cardo C, Scher HI (1995).
Prognostic value of p53 nuclear overexpression
in patients with invasive bladder
cancer treated with neoadjuvant MVAC. J
Clin Oncol 13: 1384-1390.
2294. Sarkis AS, Dalbagni G, Cordon-Cardo
C, Melamed J, Zhang ZF, Sheinfeld J, Fair
WR, Herr HW, Reuter VE (1994). Association
of P53 nuclear overexpression and tumor
progression in carcinoma in situ of the bladder.
J Urol 152: 388-392.
2295. Sarkis AS, Dalbagni G, Cordon-Cardo
C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW,
Reuter VE (1993). Nuclear overexpression of
p53 protein in transitional cell bladder carcinoma:
a marker for disease progression. J
Natl Cancer Inst 85: 53-59.
2296. Sarkis AS, Zhang ZF, Cordon CC,
Melamed J, Dalbagni G, Sheinfeld J, Fair
WR, Herr HW, Reuter VE (1993). p53 Nuclear
overexpression and disease progression in
Ta bladder carcinoma. Int J Oncol 3: 355-
360.
2297. Sarma KP (1970). Squamous cell carcinoma
of the bladder. Int Surg 53: 313-319.
2298. Sarosdy MF, Schellhammer P,
Bokinsky G, Kahn P, Chao R, Yore L, Zadra J,
Burzon D, Osher G, Bridge JA, Anderson S,
Johansson SL, Lieber M, Soloway M, Flom K
(2002). Clinical evaluation of a multi-target
fluorescent in situ hybridization assay for
detection of bladder cancer. J Urol 168:
1950-1954.
2299. Satie AP, Rajpert-de Meyts E, Spagnoli
GC, Henno S, Olivo L, Jacobsen GK, Rioux-
Leclercq N, Jegou B, Samson M (2002). The
cancer-testis gene, NY-ESO-1, is expressed
in normal fetal and adult testes and in spermatocytic
seminomas and testicular carcinoma
in situ. Lab Invest 82: 775-780.
2300. Sato D, Kase T, Tajima M, Sawamura
Y, Matsushima M, Wakayama M, Kuwajima
A (2001). Penile schwannoma. Int J Urol 8:
87-89.
2301. Sato K, Moriyama M, Mori S, Saito M,
Watanuki T, Terada K, Okuhara E, Akiyama
T, Toyoshima K, Yamamoto T, Kato T (1992).
An immunohistologic evaluation of C-erbB-2
gene product in patients with urinary bladder
carcinoma. Cancer 70: 2493-2498.
2302. Satoh E, Miyao N, Tachiki H, Fujisawa
Y (2002). Prediction of muscle invasion of
bladder cancer by cystoscopy. Eur Urol 41:
178-181.
2303. Sauter ER, Schorin MA, Farr GHJr,
Falterman KW, Arensman RM (1990). Wilms’
tumor with metastasis to the left testis. Am
Surg 56: 260-262.
2304. Sauter G, Gasser TC, Moch H, Richter
J, Jiang F, Albrecht R, Novotny H, Wagner
U, Bubendorf L, Mihatsch MJ (1997). DNA
aberrations in urinary bladder cancer
detected by flow cytometry and FISH. Urol
Res 25 Suppl 1: 37-43.
2305. Sauter G, Haley J, Chew K,
Kerschmann R, Moore D, Carroll P, Moch H,
Gudat F, Mihatsch MJ, Waldman F (1994).
Epidermal-growth-factor-receptor expression
is associated with rapid tumor proliferation
in bladder cancer. Int J Cancer 57:
508-514.
2306. Sauter G, Mihatsch MJ (1998).
Pussycats and baby tigers: non-invasive
(pTa) and minimally invasive (pT1) bladder
carcinomas are not the same! J Pathol 185:
339-341.
2307. Sauter G, Moch H, Carroll P,
Kerschmann R, Mihatsch MJ, Waldman FM
(1995). Chromosome-9 loss detected by fluorescence
in situ hybridization in bladder
cancer. Int J Cancer 64: 99-103.
2308. Sauter G, Moch H, Gudat F, Mihatsch
MJ, Haley J, Meecker T, Waldman F (1993).
[Demonstration of gene amplification in urinary
bladder cancer by fluorescent in situ
hybridization (FISH)]. Verh Dtsch Ges Pathol
77: 247-251.
2309. Sauter G, Moch H, Moore D, Carroll P,
Kerschmann R, Chew K, Mihatsch MJ, Gudat F,
Waldman F (1993). Heterogeneity of erbB-2
gene amplification in bladder cancer. Cancer
Res 53: 2199-2203.
2310. Sauter G, Moch H, Wagner U, Novotna H,
Gasser TC, Mattarelli G, Mihatsch MJ,
Waldman FM (1995). Y chromosome loss
detected by FISH in bladder cancer. Cancer
Genet Cytogenet 82: 163-169.
2311. Savla J, Chen TT, Schneider NR, Timmons
CF, Delattre O, Tomlinson GE (2000). Mutations
of the hSNF5/INI1 gene in renal rhabdoid
tumors with second primary brain tumors. J
Natl Cancer Inst 92: 648-650.
2312. Saw D, Tse CH, Chan J, Watt CY, Ng CS,
Poon YF (1986). Clear cell sarcoma of the penis.
Hum Pathol 17: 423-425.
2313. Sawczuk I, Tannenbaum M, Olsson CA,
de Vere White R (1985). Primary transitional cell
carcinoma of prostatic periurethral ducts.
Urology 25: 339-343.
2314. Sawyer JR, Tryka AF, Lewis JM (1992). A
novel reciprocal chromosome translocation
t(11;22)(p13;q12) in an intraabdominal desmoplastic
small round-cell tumor. Am J Surg
Pathol 16: 411-416.
2315. Schade RO, Swinney J (1968). Pre-cancerous
changes in bladder epithelium. Lancet 2:
943-946.
2316. Schaffer AA, Simon R, Desper R, Richter J,
Sauter G (2001). Tree models for dependent
copy number changes in bladder cancer. Int J
Oncol 18: 349-354.
2317. Schally AV, Comaru-Schally AM,
Plonowski A, Nagy A, Halmos G, Rekasi Z
(2000). Peptide analogs in the therapy of
prostate cancer. Prostate 45: 158-166.
2318. Schellhammer PF (1983). Urethral carcinoma.
Semin Urol 1: 82-89.
2319. Schellhammer PF, Whitmore WFJr (1976).
Transitional cell carcinoma of the urethra in
men having cystectomy for bladder cancer. J
Urol 115: 56-60.
2320. Schenkman NS, Moul JW, Nicely ER,
Maggio MI, Ho CK (1993). Synchronous bilateral
testis tumor: mixed germ cell and theca cell
tumors. Urology 42: 593-595.
2321. Schillinger F, Montagnac R (1996). Chronic
renal failure and its treatment in tuberous sclerosis.
Nephrol Dial Transplant 11: 481-485.
2322. Schindler S, de Frias DV, Yu GH (1999).
Primary angiosarcoma of the bladder: cytomorphology
and differential diagnosis.
Cytopathology 10: 137-143.
2323. Schips L, Augustin H, Zigeuner RE, Galle G,
Habermann H, Trummer H, Pummer K, Hubmer
G (2002). Is repeated transurethral resection
justified in patients with newly diagnosed
superficial bladder cancer? Urology 59: 220-223.
2324. Schmauz R, Cole P (1974). Epidemiology of
cancer of the renal pelvis and ureter. J Natl
Cancer Inst 52: 1431-1434.
2325. Schmidt BA, Rose A, Steinhoff C,
Strohmeyer T, Hartmann M, Ackermann R
(2001). Up-regulation of cyclin-dependent
kinase 4/cyclin D2 expression but down-regulation
of cyclin-dependent kinase 2/cyclin E in
testicular germ cell tumors. Cancer Res 61:
4214-4221.
2326. Schmidt L, Duh FM, Chen F, Kishida T,
Glenn G, Choyke P, Scherer SW, Zhuang Z,
Lubensky I, Dean M, Allikmets R, Chidambaram
A, Bergerheim UR, Feltis JT, Casadevall C,
Zamarron A, Bernues M, Richard S, Lips CJ,
Walther MM, Tsui LC, Geil L, Orcutt ML,
Stackhouse T, Lipan J, Slife L, Brauch H, Decker
J, Niehans G, Hughson MD, Moch H, Storkel S,
Lerman MI, Linehan WM, Zbar B (1997).
Germline and somatic mutations in the tyrosine
kinase domain of the MET proto-oncogene in
papillary renal carcinomas. Nat Genet 16: 68-73.
References 341